Vertex Pharmaceuticals has analysts doing financial backflips as they boost its price targets, with Royal Bank of Canada ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

Bank of America upped its price target for Vertex Pharmaceuticals from $555 to $567, signaling growing confidence in the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

One Redditor shared how they found a high-quality Shark Vertex vacuum cleaner in the trash and got it for free.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...